Geode Capital Management’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
Other funds holding ANVS
VCM
VFT
MFG
Geode Capital Management's ANVS Position: Q1 2026 in Review
Geode Capital Management increased its Annovis Bio (ANVS) stake by 11% in Q1 2026, buying an estimated $69.6K and bringing the position to 247,513 shares worth $552K. The position accounts for ﹤0.01% of the portfolio, ranked #3554.
Geode Capital Management first reported a position in ANVS in Q1 2021 and has held it in 21 quarters since. The position peaked at $3.3M in Q2 2021. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.
- Geode Capital Management held 247,513 shares of Annovis Bio worth $552K as of Q1 2026.
- Geode Capital Management bought 25,381 Annovis Bio shares in Q1 2026, an estimated $69.6K.
- Annovis Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3554 holding.
- Geode Capital Management first reported a position in Annovis Bio in Q1 2021 and has held it in 21 quarters since.
- Geode Capital Management's Annovis Bio position peaked at $3.3M in Q2 2021.
- 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.